Eye and Vision

About Conference

Step into the vibrant city of Rome, Italy, where innovation meets tradition, and embark on a journey of discovery at the esteemed 8^th World Congress on Eye and Vision. Taking place on May 16-17, 2024, this congress promises to be a beacon of knowledge and inspiration in the field of ophthalmology. With the theme "Exploring the novel research and innovations in eye and visual system" we invite you to join us in exploring the frontiers of eye care and vision science amidst the timeless beauty of Rome's historic surroundings.

Our congress aims to gather leading minds from across the globe, including ophthalmologists, optometrists, researchers, scholars, and industry professionals, to delve into the latest advancements and future prospects in eye care and vision science.

Why Attend?

The 8^th World Congress on Eye and Vision offers a unique opportunity for attendees to explore cutting-edge research, innovative technologies, and emerging trends in vision science. By participating in this event, you'll have access to enlightening keynote presentations, insightful panel discussions, interactive workshops, and networking sessions with peers and mentors.

Whether you're a seasoned professional looking to stay abreast of the latest developments or a newcomer eager to learn and connect with industry leaders, this congress is tailor-made to meet your needs. Join us in Rome to gain valuable insights, forge new collaborations, and contribute to shaping the future of eye care worldwide.

Target Audience:

• Ophthalmologists
• Optometrists
• Researchers in Vision Science
• Academicians and Scholars
• Industry Professionals
• Medical Students
• Vision Care Technicians
• Ophthalmic Nurses
• Pharmaceutical Companies
• Healthcare Providers
• Vision Rehabilitation Specialists
• Vision Therapists
• Low Vision Specialists
• Vision Scientists
• Retina Specialists
• Pediatric Ophthalmologists
• Vision Educators
• Vision Advocacy Organizations
• Community Health Workers
• Geriatric Care Providers
• Vision Technology Developers
• Telemedicine Practitioners

Don't miss this unparalleled opportunity to be part of a transformative dialogue aimed at advancing eye health and vision care on a global scale. Mark your calendars for May 16-17, 2024, and join us in Rome for an unforgettable experience at the 8^th World Congress on Eye and Vision. Together, let's shape tomorrow's sight for a brighter, clearer future.

Scientific Sessions

Track 1: Advancements in Retinal Imaging Technologies

Advancements in retinal imaging technologies have transformed the landscape of eye care, offering clinicians unprecedented insights into the structure and function of the retina. Techniques like Optical Coherence Tomography (OCT) provide detailed, cross-sectional images, enabling early detection and precise monitoring of conditions such as macular degeneration and glaucoma. Fluorescein and Indocyanine Green Angiography (FA and ICG) allow visualization of retinal blood flow, aiding in the diagnosis of diabetic retinopathy and vascular occlusions. Fundus Autofluorescence (FAF) reveals metabolic changes in the retina, while Adaptive Optics (AO) systems offer unprecedented resolution, visualizing individual retinal cells. Widefield imaging expands the scope of examination, capturing peripheral pathologies.

• High-Resolution Imaging Techniques
• Multimodal Imaging Integration
• Artificial Intelligence Applications
• Portable and Handheld Imaging Devices

Track 2: Emerging Therapies for Glaucoma Management

Emerging therapies for glaucoma management are continually evolving, aiming to address the complex pathophysiology of the disease and improve patient outcomes. One notable approach involves neuroprotection, focusing on preserving retinal ganglion cells and their axons. Various agents, including brimonidine, memantine, and cannabinoids, are being investigated for their potential neuroprotective effects. Another promising avenue is gene therapy, where viral vectors deliver therapeutic genes to target cells in the eye, promoting cell survival and enhancing optic nerve function. Additionally, regenerative medicine strategies, such as stem cell therapy and cell-based neuroprotection, hold promise for repairing damaged retinal tissue and restoring visual function. Non-invasive methods, like transcranial magnetic stimulation and photobiomodulation, are also being explored for their potential to modulate neural activity and protect against glaucomatous damage. These emerging therapies represent exciting advancements in glaucoma management, offering novel approaches to preserve vision and improve the quality of life for affected individuals.

• Neuroprotection Agents
• Gene Therapy
• Regenerative Medicine
• Non-Invasive Therapies

Track 3: Pediatric Ophthalmology: Challenges and Innovations

Pediatric ophthalmology presents unique challenges due to the complexity of diagnosing and treating eye conditions in children. Unlike adults, children may not be able to communicate their symptoms effectively, requiring specialized examination techniques and tools tailored to their developmental stage. Furthermore, conditions like amblyopia (lazy eye) and strabismus (eye misalignment) require early intervention to prevent permanent vision loss or impairment. Innovations in pediatric ophthalmology aim to address these challenges by developing child-friendly diagnostic methods, such as handheld devices and non-invasive imaging technologies. Additionally, advancements in surgical techniques, including minimally invasive procedures and adjustable sutures, help optimize outcomes while minimizing the impact on a child's developing visual system. Collaborative efforts between ophthalmologists, pediatricians, and other healthcare professionals also play a crucial role in providing comprehensive care and support for children with eye disorders.

• Diagnostic Challenges
• Treatment Complexity
• Unique Pathologies
• Child-Centered Care

Track 4: The Role of Artificial Intelligence in Ophthalmology

The role of Artificial Intelligence (AI) in ophthalmology is rapidly expanding, revolutionizing various aspects of eye care. AI algorithms analyze large datasets of retinal images, optical coherence tomography scans, and other diagnostic data to detect, classify, and predict eye diseases with high accuracy. This technology aids in early detection of conditions like diabetic retinopathy, age-related macular degeneration, and glaucoma, enabling timely intervention and preventing vision loss. Additionally, AI assists ophthalmologists in treatment planning by providing personalized recommendations based on patient-specific data. Moreover, AI-powered tools streamline administrative tasks, improve workflow efficiency, and enhance patient care delivery. As AI continues to advance, its integration into ophthalmic practice holds promise for improving diagnostic accuracy, optimizing treatment outcomes, and expanding access to quality eye care globally.

• Disease Detection and Diagnosis
• Treatment Planning and Personalized Medicine
• Clinical Decision Support Systems
• Workflow Optimization and Administrative Tasks

Track 5: Updates in Corneal Transplantation Techniques

Updates in corneal transplantation techniques have significantly improved outcomes for patients requiring corneal transplants. Traditional full-thickness penetrating keratoplasty (PK) has been largely replaced by newer, more selective procedures such as Descemet's stripping automated endothelial keratoplasty (DSAEK) and Descemet's membrane endothelial keratoplasty (DMEK). These techniques involve transplanting only the endothelial layer or a combination of endothelium and Descemet's membrane, leading to faster visual recovery, reduced risk of graft rejection, and improved long-term graft survival. Additionally, advancements in femtosecond laser technology have enhanced the precision and reproducibility of corneal transplant procedures, facilitating more predictable outcomes and minimizing surgical complications. These updates in corneal transplantation techniques represent significant progress in the field of corneal surgery, ultimately benefiting patients by preserving vision and improving quality of life.

• Selective Endothelial Keratoplasty Techniques
• Femtosecond Laser-Assisted Keratoplasty
• Artificial Corneas and Bioengineered Constructs
• Advanced Imaging and Diagnostic Tools

Track 6: Addressing Myopia Epidemic: Research and Interventions

Addressing the myopia epidemic requires a multifaceted approach involving ongoing research and targeted interventions. Research efforts focus on understanding the underlying causes of myopia development and progression, including genetic predisposition, environmental factors, and lifestyle behaviors. Studies investigate the effectiveness of various interventions aimed at slowing myopia progression and reducing the associated risks of vision impairment and ocular complications. Interventions may include outdoor activities to increase natural light exposure, minimizing near work activities, and promoting the use of specific optical devices such as multifocal or orthokeratology contact lenses. Additionally, pharmacological interventions, such as low-dose atropine eye drops, are being explored for their potential to slow myopia progression in children. Public health initiatives and educational campaigns play a crucial role in raising awareness about myopia and its implications, promoting early detection, and encouraging proactive management strategies.

• Understanding Myopia Development
• Interventions to Slow Myopia Progression
• Pharmacological Interventions
• Public Health Initiatives and Education

Track 7: Innovative Approaches in Cataract Surgery

Innovative approaches in cataract surgery have transformed the landscape of ophthalmic care, offering patients safer procedures, enhanced visual outcomes, and greater convenience. One such advancement is femtosecond laser-assisted cataract surgery (FLACS), which utilizes precise laser technology to automate key steps of the procedure, resulting in improved accuracy and reproducibility. Advanced intraocular lens (IOL) technology, including multifocal and toric lenses, provides patients with options to address presbyopia and astigmatism, reducing dependence on glasses post-surgery. Minimally invasive cataract surgery (MICS) techniques minimize surgical trauma and accelerate recovery times through smaller incisions. Additionally, emerging robotic-assisted systems promise further improvements in surgical precision and consistency. These innovative approaches collectively represent significant progress in cataract surgery, ensuring patients receive optimal care and outcomes.

• Femtosecond Laser-Assisted Cataract Surgery (FLACS)
• Advanced Intraocular Lens (IOL) Technology
• Minimally Invasive Cataract Surgery (MICS)
• Robotic-Assisted Cataract Surgery

Track 8: Neuro-ophthalmology: Insights into Visual Pathways

Neuro ophthalmology delves into the intricate relationship between the visual system and the brain, offering profound insights into visual pathways and their role in perception. By examining how visual information is processed from the eye to higher cortical centers, neuro-ophthalmologists uncover crucial details about vision loss, abnormal eye movements, and neurological disorders affecting the visual system. Through advanced imaging techniques like MRI and functional neuroimaging, coupled with electrophysiological studies, researchers gain a deeper understanding of how neural circuits encode visual stimuli and interact with other sensory modalities. These insights not only aid in diagnosing and managing various neuro-ophthalmic conditions but also contribute to broader neurological research, shedding light on fundamental principles of brain function and perception.

• Optic Nerve Disorders
• Visual Processing Centers of the Brain
• Disorders Affecting Eye Movements
• Neuro-ophthalmic Manifestations of Systemic Diseases

Track 9: Gene Therapy for Inherited Eye Diseases

Gene therapy holds significant promise in the realm of treating inherited eye diseases, offering a potential breakthrough in addressing conditions like retinitis pigmentosa and Leber congenital amaurosis. By targeting the underlying genetic mutations responsible for vision impairment, gene therapy aims to restore normal vision or slow down the progression of these debilitating conditions. The approach typically involves delivering functional genes into the retina using viral vectors or other gene delivery systems. Encouraging results from clinical trials have been reported, with some patients experiencing improvements in vision and a deceleration of degenerative processes. Despite these promising outcomes, challenges remain, including refining delivery methods to ensure effective targeting, addressing potential immune responses, and ensuring long-term safety and efficacy. Nevertheless, ongoing research in this field continues to advance, offering hope for the development of effective gene therapies that could significantly improve the lives of individuals affected by inherited eye diseases.

• Genetic Targets and Mutations
• Delivery Systems and Techniques
• Clinical Trials and Treatment Outcomes
• Challenges and Future Directions

Track 10: Exploring the Gut-Eye Axis: Implications for Ocular Health

Emerging research has sparked interest in exploring the potential connection between gut health and ocular conditions, leading to the concept of the "gut-eye axis" and its implications for ocular health. Studies suggest that the composition of gut microbiota may influence systemic inflammation and immune responses, which could in turn impact the development and progression of various ocular diseases, including dry eye disease, age-related macular degeneration, and uveitis. Understanding this bidirectional communication between the gut and the eyes opens up new avenues for preventive and therapeutic strategies. Researchers are investigating interventions such as probiotics, prebiotics, dietary modifications, and fecal microbiota transplantation to modulate gut microbiota and potentially improve ocular health. While the mechanisms underlying the gut-eye axis are still being elucidated, this emerging field holds promise for innovative approaches to managing ocular diseases by targeting gut health.

• Gut Microbiota Composition
• Systemic Inflammation and Immune Responses
• Modulating Gut Microbiota for Ocular Health
• Clinical Implications

Track 11: Advances in Contact Lens Technology

Advances in contact lens technology have revolutionized vision correction, offering wearers enhanced comfort, safety, and visual acuity. Modern contact lenses are crafted from innovative materials with superior oxygen permeability, reducing the risk of complications such as corneal hypoxia and infections, and allowing for extended wearing times. Furthermore, specialized designs cater to diverse visual needs, with options like scleral lenses for irregular corneas and multifocal lenses for presbyopia. The integration of smart technologies represents the next frontier, with sensors for monitoring intraocular pressure or drug delivery systems for treating ocular conditions being developed. These advancements not only improve the wearer's experience but also pave the way for personalized and proactive eye care. As research continues to drive innovation, contact lenses are poised to play an increasingly significant role in addressing vision challenges and promoting ocular health in the future.

• Enhanced Comfort and Safety
• Customized Designs for Diverse Needs
• Integration of Smart Technologies
• Future Directions and Research Frontiers

Track 12: Optic Nerve Disorders: Diagnosis and Management

Optic nerve disorders encompass a spectrum of conditions affecting the optic nerve, crucial for transmitting visual information from the eye to the brain. Diagnosis typically involves a comprehensive ophthalmologic examination, including visual acuity testing, pupillary reflex assessment, visual field testing, and imaging modalities such as optical coherence tomography (OCT) and magnetic resonance imaging (MRI). Management strategies aim to address underlying causes, alleviate symptoms, and prevent further damage to the optic nerve. Treatment may involve medications, such as corticosteroids for inflammatory conditions or neuroprotective agents for optic neuropathies. Surgical interventions, such as optic nerve decompression for optic nerve head swelling, may be necessary in certain cases. Additionally, lifestyle modifications and vision rehabilitation programs can help optimize visual function and quality of life for individuals affected by optic nerve disorders. Early detection and prompt intervention are critical in preserving vision and minimizing complications associated with these conditions.

• Diagnostic Techniques
• Etiology and Classification
• Medical Management
• Surgical Interventions and Rehabilitation

Track 13: Ocular Surface Disease: From Bench to Bedside

Ocular Surface Disease (OSD) refers to a group of disorders affecting the outermost layer of the eye, including the cornea and conjunctiva. This encompasses a wide range of conditions, such as dry eye syndrome, blepharitis, and ocular allergies. OSD can lead to symptoms such as irritation, redness, tearing, and blurred vision, significantly impacting the patient's quality of life. Advancements in understanding the pathophysiology of OSD have led to developments in diagnostic and treatment modalities, bridging the gap from laboratory research to clinical practice. Diagnostic tools such as tear film osmolarity measurement, meibomian gland imaging, and inflammatory biomarker analysis aid in accurate assessment and personalized management strategies. Treatment approaches for OSD vary depending on the underlying cause and severity of the condition. This may include artificial tear supplementation, anti-inflammatory medications, lid hygiene practices, and in severe cases, surgical interventions such as punctal plugs or amniotic membrane transplantation.

• Pathophysiology and Biomarkers
• Diagnostic Innovations
• Therapeutic Strategies
• Translational Research and Clinical Implementation

Track 14: Vision Rehabilitation: Enhancing Quality of Life

Vision rehabilitation plays a pivotal role in enhancing the quality of life for individuals experiencing vision loss or impairment due to various ocular conditions, such as age-related macular degeneration, diabetic retinopathy, glaucoma, or retinitis pigmentosa. Through a comprehensive and multidisciplinary approach, vision rehabilitation aims to maximize functional vision, promote independence, and improve overall well-being. This includes tailored interventions such as low vision aids, orientation and mobility training, adaptive technology, and psychological support to address the physical, emotional, and social aspects of vision loss. By empowering individuals to adapt to their visual challenges and regain confidence in daily activities, vision rehabilitation enables them to lead fulfilling and meaningful lives despite their visual limitations.

• Personalized Assessment
• Assistive Technology
• Skills Training and Adaptive Techniques
• Psychosocial Support

Track 15: Understanding the Role of Inflammation in Eye Disorders

Understanding the role of inflammation in eye disorders is crucial for developing effective diagnostic and treatment strategies. Inflammation serves as a common pathway in various ocular conditions, including uveitis, conjunctivitis, and age-related macular degeneration, among others. Inflammatory processes can disrupt normal ocular physiology, leading to tissue damage, impaired visual function, and, in severe cases, vision loss. By elucidating the mechanisms underlying ocular inflammation, researchers can identify novel therapeutic targets and develop targeted interventions to modulate immune responses and mitigate tissue damage. Furthermore, recognizing the inflammatory component in eye disorders allows clinicians to implement timely interventions, such as anti-inflammatory medications or immunomodulatory therapies, to manage inflammation and preserve ocular health. Overall, a deeper understanding of the role of inflammation in eye disorders holds promise for improving patient outcomes and reducing the burden of vision-threatening conditions.

• Pathophysiological Mechanisms
• Immunological Factors
• Clinical Manifestations and Diagnostic Approaches
• Therapeutic Strategies

Track 16: Teleophthalmology: Bridging Gaps in Eye Care

Teleophthalmology plays a vital role in bridging gaps in eye care by leveraging telecommunications technology to provide remote diagnosis, consultation, and management of ocular conditions. Particularly beneficial in underserved or remote areas lacking access to specialized eye care, teleophthalmology facilitates timely and efficient delivery of services, overcoming barriers of distance and limited resources. Through teleconsultations, patients can receive expert evaluation and guidance from ophthalmologists without the need for physical travel, reducing wait times and healthcare costs. Moreover, teleophthalmology enables screening programs for diabetic retinopathy, glaucoma, and other sight-threatening conditions, facilitating early detection and intervention. By expanding access to eye care services and promoting collaboration among healthcare providers, teleophthalmology contributes to improving visual outcomes and reducing the global burden of preventable blindness.

• Remote Consultations
• Screening Programs for Underserved Populations
• Accessible Eye Care for Rural Communities
• Collaborative Care and Knowledge Sharing

Track 17: Drug Delivery Systems for Ocular Disorders

Drug delivery systems for ocular disorders play a pivotal role in enhancing the efficacy and safety of therapeutic interventions while addressing the unique challenges posed by ocular anatomy and physiology. These systems encompass a variety of formulations and technologies designed to optimize drug delivery to the targeted ocular tissues, including the cornea, conjunctiva, retina, and intraocular structures. From conventional eye drops and ointments to innovative nanoformulations, implants, and sustained-release devices, these systems aim to improve drug bioavailability, prolong therapeutic effects, and minimize systemic side effects. By overcoming barriers such as tear turnover, rapid clearance, and limited ocular penetration, drug delivery systems contribute to the management of various ocular disorders, including glaucoma, retinal diseases, ocular inflammation, and infections. Continued advancements in formulation design, nanotechnology, and biomaterials hold promise for further improving the precision, efficacy, and patient compliance of ocular drug delivery systems, ultimately enhancing therapeutic outcomes and quality of life for individuals with ocular disorders.

• Nanotechnology-Based Drug Delivery
• Sustained-Release Implants and Inserts
• Mucoadhesive and In Situ Gelling Formulations
• Ocular Inserts and Contact Lenses

Track 18: Ophthalmic Epidemiology: Insights from Population Studies

Ophthalmic epidemiology draws critical insights from population studies to understand the prevalence, incidence, risk factors, and burden of eye diseases within communities. By examining large cohorts over extended periods, researchers can identify trends, disparities, and patterns of ocular conditions such as cataracts, glaucoma, age-related macular degeneration, and diabetic retinopathy. Epidemiological data provide valuable information for healthcare planning, resource allocation, and public health interventions aimed at preventing, detecting, and managing eye diseases. Furthermore, population-based studies enable the identification of modifiable risk factors, genetic predispositions, and environmental influences contributing to ocular health outcomes, informing targeted strategies for disease prevention and health promotion. Through collaborative efforts between researchers, clinicians, policymakers, and community stakeholders, ophthalmic epidemiology plays a crucial role in advancing our understanding of eye health and guiding evidence-based approaches to improve vision outcomes on a population level.

• Prevalence and Incidence Rates of Ocular Diseases
• Determinants of Ocular Health
• Longitudinal Cohort Studies
• Health Services Research and Access to Eye Care

Track 19: Nutrition and Eye Health: Latest Evidence

Nutrition plays a pivotal role in maintaining optimal eye health, with emerging evidence highlighting the impact of dietary factors on various ocular conditions. Research suggests that a diet rich in antioxidants, vitamins, minerals, and omega-3 fatty acids can help protect against age-related macular degeneration (AMD), cataracts, and other vision-threatening diseases. Antioxidants such as lutein, zeaxanthin, vitamin C, and vitamin E, found abundantly in fruits, vegetables, and leafy greens, help neutralize free radicals and reduce oxidative stress in the eyes. Similarly, omega-3 fatty acids, predominantly found in fish, nuts, and seeds, have anti-inflammatory properties that may mitigate the progression of AMD and dry eye syndrome. Furthermore, nutrients like zinc and vitamin A are essential for maintaining the structural integrity of ocular tissues and supporting optimal visual function. By incorporating evidence-based dietary recommendations into public health initiatives and clinical practice, individuals can promote long-term eye health and potentially reduce the risk of vision loss associated with age-related ocular diseases.

• Antioxidants and Eye Health
• Omega-3 Fatty Acids
• Visual Function
• Ocular Disease Prevention

Track 20: Regenerative Medicine in Ophthalmology: Current Status and Future Directions

Regenerative medicine holds immense promise in revolutionizing the field of ophthalmology, offering novel approaches for treating sight-threatening conditions and restoring visual function. Current research efforts focus on harnessing the regenerative potential of stem cells, tissue engineering, and gene therapy to repair damaged ocular tissues and regenerate lost vision. Stem cell-based therapies, including induced pluripotent stem cells (iPSCs) and mesenchymal stem cells (MSCs), show potential for replacing damaged retinal cells in conditions such as age-related macular degeneration (AMD), retinitis pigmentosa, and glaucoma. Tissue engineering techniques aim to develop bioengineered corneas, retinas, and optic nerves for transplantation, offering hope for patients with corneal blindness or irreversible retinal degeneration. Furthermore, gene therapy approaches target inherited retinal diseases by delivering therapeutic genes to restore normal cellular function. While challenges remain in optimizing safety, efficacy, and scalability, regenerative medicine holds the promise of transforming ophthalmic care, offering hope for improved outcomes and vision restoration for individuals affected by debilitating eye conditions.

• Stem Cell Therapies
• Tissue Engineering
• Gene Therapy for Inherited Retinal Diseases
• Clinical Translation and Regulatory Challenges

Market Analysis

In Rome, ophthalmology stands as a specialty where private services have gained prevalence over public healthcare options. Similar to Finland, other medical fields such as dental care and gynecology also witness a significant proportion of private service provision. In 2006, both gynecology and ophthalmology accounted for over one-third of all private specialist visits. Presently, approximately two out of three ophthalmology patients are managed by the private sector. Eye vision services are predominantly offered by both public and private specialists in outpatient clinics or hospitals, as well as by optometrists in optical stores. Additionally, general practitioners (GPs) within occupational health care (OHC) and health centers also contribute to eye care services. The ophthalmology service system in Rome is characterized by its multiplicity, offering various pathways for accessing care. This landscape mirrors the trends observed in Finland, particularly with regards to the increasing interest in redefining boundaries between public and private sectors, akin to the New Public Management (NPM) initiatives witnessed in the 1970s.

UNIVERSITIES IN WORLD

• Sapienza University of Rome
• Tor Vergata University of Rome
• University of California, San Francisco
• Catholic University of the Sacred Heart
• Johns Hopkins University
• University of Rome Foro Italico
• University College London
• European University of Rome
• Harvard University
• University of Oxford
• University of Cambridge
• University of Michigan
• Stanford University
• Moorfields Eye Hospital and UCL Institute of Ophthalmology
• Bascom Palmer Eye Institute, University of Miami
• Wilmer Eye Institute, Johns Hopkins University
• Duke University
• University of Pennsylvania
• University of Melbourne
• University of Washington
• University of Tokyo
• Columbia University
• University of California
• University of Heidelberg
• University of Manchester

BELOW IS A COMPILATION OF COMPANIES WORLDWIDE THAT MANUFACTURE OPHTHALMOLOGICAL PRODUCTS

• Alcon (a subsidiary of Novartis)
• Johnson & Johnson Vision Care
• Bausch + Lomb (a subsidiary of Bausch Health Companies Inc.)
• Zeiss
• Allergan (acquired by AbbVie)
• CooperVision (a subsidiary of The Cooper Companies)
• Essilor (merged with Luxottica to form EssilorLuxottica)
• Topcon Corporation
• Haag-Streit
• NIDEK
• Santen Pharmaceutical
• Hoya Corporation
• Carl Zeiss Meditec AG
• STAAR Surgical Company
• Ziemer Ophthalmic Systems AG
• Lumenis
• Ocular Therapeutix
• AcuFocus
• Omeros Corporation
• Iridex Corporation

Past Conference Report

The 7^th World Congress on Eye and Vision, held during November 06-07, 2023, in Stockholm, Sweden, gathered academic and professional researchers, along with practitioners dedicated to advancing education and expertise in ophthalmology and vision care. Conference Series played a pivotal role in convening a substantial panel of influential members from the ophthalmology community, spanning research institutions, industry, academia, and financial organizations, to discuss the future of eye care specializations. The conference aimed to foster intellectual discourse and cultivate fresh perspectives in the fields of eye health and vision care. Its primary objective was to envision the future landscape of ophthalmology, exploring emerging trends and opportunities for advancement in the field.